NCT05589896 2026-02-24A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic MalignanciesOssium Health, Inc.Phase 1/2 Recruiting12 enrolled
NCT03802695 2026-02-23A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic MalignanciesOrca Biosystems, Inc.Phase 1 Recruiting300 enrolled
NCT07216443 2026-02-23Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeOrca Biosystems, Inc.Phase 2 Recruiting80 enrolled
NCT06533579 2026-02-12Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)Vironexis Biotherapeutics Inc.Phase 1/2 Recruiting32 enrolled
NCT04872478 2026-01-08Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPALMeryx, Inc.Phase 1 Recruiting50 enrolled
NCT04067336 2025-11-10First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid LeukemiaKura Oncology, Inc.Phase 1/2 Recruiting263 enrolled 1 FDA